Spineway SA (FRA:37S)

Market Cap	3.25M +32.3%
Revenue (ttm)	12.43M -2.4%
Net Income	-2.24M
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62
Average Volume	11,216
Open	0.1548
Previous Close	0.1500
Day's Range	0.1548 - 0.1558
52-Week Range	0.0846 - 0.2625
Beta	n/a
RSI	46.29
Earnings Date	Feb 17, 2026

About Spineway

Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2005
• Employees: 43
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 37S

Financial Performance

In 2025, Spineway's revenue was 12.43 million, a decrease of -2.38% compared to the previous year's 12.73 million. Losses were -2.24 million, -42.10% less than in 2024.